PKI 14-22 amide, myristoylated

PKI (14-22) amide (myristoylated) is cell-permeable protein kinase A inhibitor. The non-myristoylated type of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA), N-terminus is myristoylated to increase cell membrane permeability. It is usually used to study PKA in cellular systems in-vitro.

Online Inquiry

CAT#R0879
CAS201422-03-9
Synonyms/AliasProtein kinase inhibitor-(14-22)-amide, myristoylated
M.F/FormulaC53H100N20O12
M.W/Mr.1209.5
SequenceMyr-GRTGRRNAI-NH2
Labeling TargetProtein kinase A
AppearanceWhite lyophilised solid
Purity>98% (or refer to the Certificate of Analysis)
ActivityInhibitor
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

Foreword We live in a photoshopped world, where we are constantly updated by images of digital perfection. It's easy to becom ...

  st-Ht31, a protein kinase A (PKA)-anchoring inhibitor, greatly induces robust cholesterol or phospholipid effl ...

  R18 peptide is a non-phosphorylated ligand of 14-3-3 that was originally isolated from a phage display screen, ...

 Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...

 Long-term potentiation (LTP) is a persistent synaptic enhancement which is thought to be a substrate for memory. ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.